ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,523Medicare Part D Prescriptions Filled, Including Refills

Rank: 573 out of 5176

$658K Total Retail Price of All Prescriptions

Rank: 700 out of 5176

439 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 439 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 439 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 9,270 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 455 418 1 8
LEVOTHYROXINE SODIUM 416 401 2 4
METOPROLOL TARTRATE 332 294 3 6
WARFARIN SODIUM 324 324 4 13
AMLODIPINE BESYLATE 264 239 5 2
SIMVASTATIN 247 217 6 1
DONEPEZIL HCL 229 229 7 28
LISINOPRIL 222 186 8 5
SPIRONOLACTONE 210 196 9 88
DIVALPROEX SODIUM 183 156 10 104
HYDROCHLOROTHIAZIDE 161 154 11 10
GABAPENTIN 161 144 11 21
SERTRALINE HCL 160 150 13 30
OMEPRAZOLE 155 146 14 3
TRAZODONE HCL 139 131 15 71
CYMBALTA 122 89 16 90
LOSARTAN POTASSIUM 120 111 17 14
POTASSIUM CHLORIDE 119 115 18 34
METOPROLOL SUCCINATE 117 117 19 11
TAMIFLU 116 107 20 231
CITALOPRAM HBR 115 110 21 31
GLIPIZIDE 109 101 22 63
METFORMIN HCL 103 64 23 7
HYDROCODONE-ACETAMINOPHEN 101 82 S3 24 27
RISPERIDONE 98 86 25 78
NAMENDA 96 96 26 47
CLONIDINE HCL 95 78 27 79
DIVALPROEX SODIUM ER 89 87 28 270
PREDNISONE 87 87 29 52
PRAVASTATIN SODIUM 86 64 30 23
LEVETIRACETAM 85 59 31 92
BUSPIRONE HCL 82 74 32 183
BISOPROLOL FUMARATE 82 72 32 239
MIRTAZAPINE 82 80 32 45
QUETIAPINE FUMARATE 80 58 35 75
TAMSULOSIN HCL 77 63 36 20
LACTULOSE 76 76 37 87
ALBUTEROL SULFATE 75 51 38 99
CARVEDILOL 73 61 39 24
IPRATROPIUM-ALBUTEROL 73 72 39 138
HYDRALAZINE HCL 70 68 41 73
RAMIPRIL 68 68 42 50
POLYETHYLENE GLYCOL 3350 68 53 42 74
CARBIDOPA-LEVODOPA 67 55 44 98
LANTUS 65 50 45 66
CIPROFLOXACIN HCL 60 58 46 84
ISOSORBIDE MONONITRATE ER 59 59 47 44
ATORVASTATIN CALCIUM 59 49 47 9
ATENOLOL 57 57 49 12
EXELON 55 55 50 162
ABILIFY 55 55 50 273
VENLAFAXINE HCL 55 45 50 309
ESCITALOPRAM OXALATE 54 40 53 89
METOCLOPRAMIDE HCL 54 36 53 176
TRAMADOL HCL 52 50 55 40
DILTIAZEM 24HR CD 50 50 56 119
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.